Home | Covid-19 and the anti-vax movement
In this issue
Contents
Accurate Biometrics Company Insight
Accurate Biometrics
Contract Pharmaceuticals Limited Canada
Mettler Toledo Company Insight
Mettler Toledo
Briefing
Industry news
The pharma industry briefing
Covid-19 executive briefing by GlobalData
Wipotec
Purolite
VEGA Australia
Gerteis Company Insight
Gerteis
Comment
US election: Trump and Biden's priorities in the Covid-19 response
Covid-19 disruption to trials declines, but recruitment is slow
Covid-19 vaccine developments across the globe
Eli Lilly and Regeneron’s EUA bids trigger concerns over available Covid-19 data
AstraZeneca’s quick Covid-19 vaccine trial restart splits opinion
Q&A: Atomwise’s journey from discoverer to developer
Pfeiffer Vacuum
Koehler eClinical
Phoenix Company Insight
Phoenix
In Depth
How to combat vaccine hesitancy in the age of Covid-19
How Covid-19 has put clinical research’s diversity problem in the spotlight
No need for animal testing: improving vaccine research with Genoskin
Gout: drug development for an age-old disease
Treating chronic primary pain in the UK
Breast cancer breakthrough: could a new therapy silence stubborn TNBC?
Is quantum computing pharma's next big disruptor?
Mimotopes
Optel
Solvias Company Insight
Solvias
HOF Sonderanlagenbau Company Insight
HOF Sonderanlagenbau
In Data
Inside the deal
Deals analysis
The pharma industry key list
Global markets and indices
Macro-economic indicators
Macro-economic indicators (page 2)
IWA Consulting Company Insight
IWA consulting
Nipro pharmapackaging
Swiftpak
Events
Next issue
10/23/2020 00:00:00
Go to article:
Home | Covid-19 and the anti-vax movement
Go to article:
In this issue
Go to article:
Contents
Go to article:
Accurate Biometrics Company Insight
Go to article:
Accurate Biometrics
Go to article:
Contract Pharmaceuticals Limited Canada
Go to article:
Mettler Toledo Company Insight
Go to article:
Mettler Toledo
Go to article:
Briefing
Go to article:
Industry news
Go to article:
The pharma industry briefing
Go to article:
Covid-19 executive briefing by GlobalData
Go to article:
Wipotec
Go to article:
Purolite
Go to article:
VEGA Australia
Go to article:
Gerteis Company Insight
Go to article:
Gerteis
Go to article:
Comment
Go to article:
US election: Trump and Biden's priorities in the Covid-19 response
Go to article:
Covid-19 disruption to trials declines, but recruitment is slow
Go to article:
Covid-19 vaccine developments across the globe
Go to article:
Eli Lilly and Regeneron’s EUA bids trigger concerns over available Covid-19 data
Go to article:
AstraZeneca’s quick Covid-19 vaccine trial restart splits opinion
Go to article:
Q&A: Atomwise’s journey from discoverer to developer
Go to article:
Pfeiffer Vacuum
Go to article:
Koehler eClinical
Go to article:
Phoenix Company Insight
Go to article:
Phoenix
Go to article:
In Depth
Go to article:
How to combat vaccine hesitancy in the age of Covid-19
Go to article:
How Covid-19 has put clinical research’s diversity problem in the spotlight
Go to article:
No need for animal testing: improving vaccine research with Genoskin
Go to article:
Gout: drug development for an age-old disease
Go to article:
Treating chronic primary pain in the UK
Go to article:
Breast cancer breakthrough: could a new therapy silence stubborn TNBC?
Go to article:
Is quantum computing pharma's next big disruptor?
Go to article:
Mimotopes
Go to article:
Optel
Go to article:
Solvias Company Insight
Go to article:
Solvias
Go to article:
HOF Sonderanlagenbau Company Insight
Go to article:
HOF Sonderanlagenbau
Go to article:
In Data
Go to article:
Inside the deal
Go to article:
Deals analysis
Go to article:
The pharma industry key list
Go to article:
Global markets and indices
Go to article:
Macro-economic indicators
Go to article:
Macro-economic indicators (page 2)
Go to article:
IWA Consulting Company Insight
Go to article:
IWA consulting
Go to article:
Nipro pharmapackaging
Go to article:
Swiftpak
Go to article:
Events
Go to article:
Next issue